Provided by Tiger Trade Technology Pte. Ltd.

Insmed

164.91
+3.912.43%
Post-market: 164.910.00000.00%16:55 EST
Volume:4.13M
Turnover:677.39M
Market Cap:34.86B
PE:-26.52
High:167.37
Open:158.39
Low:157.77
Close:161.00
52wk High:212.75
52wk Low:60.40
Shares:211.37M
Float Shares:194.00M
Volume Ratio:1.51
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.2193
EPS(LYR):-5.5703
ROE:-165.69%
ROA:-28.05%
PB:36.86
PE(LYR):-29.61

Loading ...

Insmed Is Maintained at Overweight by Wells Fargo

Dow Jones
·
3 hours ago

Insmed Q4 Reinforces Confidence in Brinsupri Growth, RBC Says

MT Newswires Live
·
Yesterday

Insmed May Top Revenue Target for Bronchiectasis Drug Brinsupri, Morgan Stanley Says

MT Newswires Live
·
Yesterday

RBC Capital Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
Yesterday

Pre-Bell | U.S. Futures Muted; Opendoor Surges 19%; AppLovin Jumps 5%; Alphabet Gains 1%; Grail Sinks 49%

Tiger Newspress
·
Yesterday

Bank of America Securities Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
Yesterday

Morgan Stanley Lifts Price Target on Insmed to $166 From $162, Keeps Equalweight Rating

MT Newswires Live
·
Yesterday

Insmed’s Brinsupri Launch Recasts Growth Outlook

TIPRANKS
·
Yesterday

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST on 2026-02-19

Reuters
·
Yesterday

BUZZ-Insmed rises as quarterly revenue beats estimates

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Talkspace (TALK) and Insmed (INSM)

TIPRANKS
·
Yesterday

Insmed price target lowered to $205 from $212 at Stifel

TIPRANKS
·
Yesterday

Stock Track | Insmed Soars 5.38% Intraday on Strong Q4 Revenue Beat and Optimistic 2026 Guidance

Stock Track
·
Yesterday

BRIEF-Insmed Reports Fourth-Quarter And Full-Year 2025 Financial Results And Provides Business Update

Reuters
·
Feb 19

Insmed Shares Fall 3% Premarket After Q4 Results

THOMSON REUTERS
·
Feb 19

Insmed provides 2026 outlook

TIPRANKS
·
Feb 19

Earnings Flash (INSM) Insmed Posts Q4 Loss $1.54 a Share, vs. FactSet Est of $1.02 Loss

MT Newswires Live
·
Feb 19

Insmed Q4 product revenues hit USD 263.84 million, up 153%

Reuters
·
Feb 19

Insmed Q4 EPS $(1.54) Misses $(1.12) Estimate, Sales $263.843M Beat $221.898M Estimate

Benzinga
·
Feb 19

Insmed Inc - Expects 2026 Brinsupri Revenues to Exceed $1 Bln

THOMSON REUTERS
·
Feb 19